Editorial Preview2024-07-23T02:13:08+00:00

Editorial Preview

EyeWorld Asia-Pacific September issue 2024

Feature: Precision & Perfection

Space Closing: 16 August 2024

Materials Due: 23 August 2024

Highlights from the 36th APACRS- 24th CSCRS Joint Meeting Chengdu, 2024

  • Tales of the Flanging Technique

Dr Shin Yamane elaborated in depth on the flanging technique during the 2024 APACRS LIM Lecture.

  • Pathways to Precision and Perfection

The Combined Symposium of the Cataract & Refractive Societies (CSCRS) explores three areas of contention which present along the constant pursuit of precise and perfect surgical outcomes.

  • The Perfect Save!

The IIIC Symposium presented “The Perfect Save!” where challenging situations are presented, with solutions offered.

  • Top Tips from the Wisdom from the Kung Fu Masters

Editor’s picks on some of the subtle surgical tips and maneuvers presented in the Wisdom of the Kung Fu Masters session.

  • Comparing bimanual and coaxial I/A

Choosing between bimanual or coaxial I/A depends on factors like physician preference and case type. Two surgeons discuss what may be beneficial.

  • “I wish I identified and treated ABMD before cataract surgery”

Irritated eyes, fluctuating vision and more — common phrases like these are what an ophthalmologist would hear when missing preoperative treatment of ABMD.

  • Tips for IOL exchange

Two cornea and refractive specialists share pearls for performing IOL exchanges, initial diagnostic steps to rule out other reasons for poor quality vision, as well as the importance of having a comprehensive plan of attack.

  • What the decline in LASIK procedures means for refractive surgery as a whole

LASIK volumes in the U.S. have declined over the last year, but several EyeWorld Editorial Board members comment on their recent observations with LASIK volumes, and how this isn’t necessarily a bad thing for refractive surgery volume as a whole.

  • Wish granted: more ocular surface options

For years, ophthalmologists had limited prescription options for patients with ocular surface disease. In the last decade, the number of available options have grown, with several receiving approval in 2023. Two experts shared their thoughts and experiences.

  • Antiviral treatment for HSV

Two ophthalmologists discuss the antiviral treatment options available for HSV, including topical and oral options, when to get patients treated, how quickly the treatment works, and how this can impact patients in the future.

  • Sustainability in the Asia-Pacific